VF
VERA icon

Virtu Financial’s Vera Therapeutics VERA Stock Holding History

Virtu Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,870
Closed -$297K – 2347
2025
Q4 		$297K Buy
+5,870
New +$208K 0.01% 857
2024
Q2 		– Sell
-8,704
Closed -$375K – 1911
2024
Q1 		$375K Buy
+8,704
New +$310K 0.03% 526
2023
Q2 		– Sell
-10,481
Closed -$81K – 2069
2023
Q1 		$81K Buy
+10,481
New +$80.9K 0.01% 1022

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Virtu Financial's VERA Position: Q1 2026 in Review

Virtu Financial sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 5,870 shares — an estimated $297K sold.

Virtu Financial first reported a position in VERA in Q1 2023 and held it in 3 quarters. The position peaked at $375K in Q1 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Virtu Financial reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 5,870 Vera Therapeutics shares in Q1 2026, an estimated $297K.
  • Virtu Financial first reported a position in Vera Therapeutics in Q1 2023 and held it in 3 quarters.
  • Virtu Financial's Vera Therapeutics position peaked at $375K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.